XML 10 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Operating expenses:        
Research and development $ 39,951 $ 33,226 $ 114,477 $ 92,218
General and administrative 5,926 4,395 14,137 13,272
Total operating expenses 45,877 37,621 128,614 105,490
Loss from operations (45,877) (37,621) (128,614) (105,490)
Other income:        
Interest income 3,648 2,928 12,214 9,388
Other income 12 138 10 195
Total other income 3,660 3,066 12,224 9,583
Net loss $ (42,217) $ (34,555) $ (116,390) $ (95,907)
Net loss per share, basic (in dollars per share) $ (0.49) $ (0.6) $ (1.36) $ (1.8)
Net loss per share, diluted (in dollars per share) $ (0.49) $ (0.6) $ (1.36) $ (1.8)
Weighted average shares used to compute net loss per share, basic (in shares) 85,732,221 57,262,803 85,553,078 53,194,081
Weighted average shares used to compute net loss per share, diluted (in shares) 85,732,221 57,262,803 85,553,078 53,194,081